Key result
Pediatric heparinoid use is frequent, but suspected heparin-induced thrombocytopenia remains rare with only 4 cases over 2 years.
Cross-Sectional (n=116)
No
Answers are grounded in this paper and cite their sources.
OBJECTIVE: To audit the frequency of heparinoid (standard heparin and low molecular weight heparin) use in a tertiary paediatric hospital, and to determine the occurrence of heparin-induced thrombocytopenia (HIT). METHODS: A 1-week cross-sectional audit of all heparinoids given to inpatients at a tertiary paediatric hospital was undertaken and a retrospective medical record review of all suspected HIT cases at the tertiary paediatric centre over a 2-year period was carried out. RESULTS: One hundred and sixteen patients received heparinoid medications over a 7-day period. An average of 29 children received heparin daily. The retrospective medical record review identified four patients with suspected HIT over a 2-year period. Two patients developed thrombotic complications, which were fatal in one patient. CONCLUSION: Heparin is used frequently in paediatric tertiary hospitals, yet the occurrence of HIT in children is much lower than that reported in adults. Improved laboratory techniques could facilitate improved screening and diagnosis of this serious adverse drug reaction.
No takes yet. Share an insight, caveat, or question.
Newall et al. (2003) conducted a cross-sectional in Heparin-induced thrombocytopenia (HIT) (n=116). Heparinoid medications (standard heparin and low molecular weight heparin) was evaluated on Occurrence of heparin-induced thrombocytopenia (HIT) and frequency of heparinoid use.
Synapse has enriched 10 related papers. Consider them for comparative context: